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Abstract
Objective To assess how initial severity of depression affects the benefit
derived from low intensity interventions for depression.
Design Meta-analysis of individual patient data from 16 datasets
comparing low intensity interventions with usual care.
Setting Primary care and community settings.
Participants 2470 patients with depression.
Interventions Low intensity interventions for depression (such as guided
self help by means of written materials and limited professional support,
and internet delivered interventions).
Main outcome measures Depression outcomes (measured with the
Beck Depression Inventory or Center for Epidemiologic Studies
Depression Scale), and the effect of initial depression severity on the
effects of low intensity interventions.
Results Although patients were referred for low intensity interventions,
many had moderate to severe depression at baseline. We found a
significant interaction between baseline severity and treatment effect
(coefficient −0.1 (95% CI −0.19 to −0.002)), suggesting that patients
who are more severely depressed at baseline demonstrate larger
treatment effects than those who are less severely depressed. However,
the magnitude of the interaction (equivalent to an additional drop of
around one point on the Beck Depression Inventory for a one standard
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deviation increase in initial severity) was small and may not be clinically
significant.
Conclusions The data suggest that patients with more severe
depression at baseline show at least as much clinical benefit from low
intensity interventions as less severely depressed patients and could
usefully be offered these interventions as part of a stepped care model.
Introduction
Depression is a major cause of disability among populations
worldwide,1 and effective management is a key challenge for
healthcare systems. In response, some have recommended a
stepped care approach,2 and this has been adopted as the basis
for depression services in the UK.3 In stepped care, a large
proportion of patients are first treated with “low intensity”
psychological interventions,4 which are generally based on
cognitive behavioural therapy and delivered via writtenmaterials
or information technology with limited professional guidance
(see box 1). Evidence suggests low intensity interventions
provide significant clinical benefit.5 6 In stepped care,
conventional high intensity interventions (such as 12–16 sessions
of therapist led cognitive behavioural therapy) are offered only
to those who fail to respond to initial low intensity interventions,
or to those deemed inappropriate for such interventions. Low
intensity interventions are the primary form of care for hundreds
of thousands of depressed patients in the UK through the
Improving Access to Psychological Therapies (IAPT) scheme.
At present, one of the key variables determining who gets low
intensity and high intensity psychological therapy is initial
severity of depression. However, the thresholds used in decision
making vary and are largely based on epidemiological studies
and accumulated clinical experience rather than high quality
evidence of the empirical relationship between initial severity
and outcome in low intensity interventions. This is critical, as
the proportion of patients with depression receiving low intensity
interventions as a first intervention varies in practice, but is a
key driver of the effectiveness of stepped care and patient
experience in depression services.7
Variables which predict response to interventions are described
as moderators of treatment effect.8 Despite the existence of a
relatively large literature on the effectiveness of low intensity
interventions,5 9-12 there is relatively little rigorous evidence on
the critical clinical question of whether initial severity moderates
effectiveness of low intensity interventions—that is, do more
severely ill patients show better or worse treatment effects?
Study level meta-analyses12 13 of these relationships lack
precision and are vulnerable to ecological bias.14 Individual
studies often report moderators as secondary analyses, but their
yield has been limited by scarcity, selective reporting,15
inappropriate methods,8 16 and low power, as sample sizes
required to achieve power to detect moderators are potentially
very high.17 This has limited the clinical utility of such analyses.
Individual patient data meta-analysis has the potential to
overcome these difficulties and place clinical decision making
in stepped care services on a much firmer footing. This form of
analysis can overcome sample size and reporting issues, allow
the application of standardised analyses across multiple datasets,
and can allow more sophisticated modelling of moderator
effects, including the inclusion of covariates and imputation of
missing data.18
We describe an individual patient data meta-analysis of
depression severity as a moderator of the effect of low intensity
interventions in depression,19 to overcome this gap in the
published evidence and make a substantive contribution to




We primarily used published systematic reviews known to the
review team as an efficient and effective method to identify
trials meeting our inclusion criteria.5 6 9-12 20-23 We updated these
with additional searches of the Cochrane Library in July 2011
(see “Additional resources” file on bmj.com for search strategy).
We also asked authors of studies identified from the published
reviews to identify additional published studies and other trials
in progress.
Inclusion criteria for studies
Population—We included studies of patients with depression
or mixed depression and anxiety, defined on the basis of research
or clinical diagnosis, a minimum score on a depression self
report scale, or self assessment. Studies of patients with anxiety
were excluded unless 50% also achieved a depression diagnosis
or the mean depression score met common criteria for
“caseness.”
Context—We included patients managed in non-hospital settings
(community and primary care), the settings in which low
intensity interventions are most commonly deployed.
Intervention—We defined low intensity interventions as those
designed to help patients manage depressive symptoms,
primarily using a health technology such as self help books,
instructional videos, or interactive interventions using
information technology. These interventions were conducted
predominantly independent of professional or paraprofessional
contact (defined as ≤3 hours of contact). We excluded self help
groups and any low intensity intervention delivered as part of
a wider intervention such as “collaborative care.”
Other criteria—To maximise the possibility of data being
available and to ensure that the analyses involved relatively
recent low intensity interventions, we restricted our analysis to
trials reported in 2000 or later. We also restricted our analysis
to studies with a sample size of more than 50, to ensure that the
logistical effort in obtaining, cleaning, and organising the data
was commensurate with the contribution to the analysis.18 The
study protocol is available in the “Additional resources” file on
bmj.com..
Data preparation and analysis
We sought primary datasets from study authors, with the
following core variables: randomised group, baseline depression
measures, follow-up depression measures, age, and sex. We
combined the datasets into a single archive and conducted
analyses to ensure that variables were correctly specified and
that initial analyses of individual datasets were consistent with
published data.
Measure standardisation
Almost all studies either used the Beck Depression Inventory
(BDI)24 or Center for Epidemiologic Studies Depression Scale
(CES-D)25 as the main depression outcome. We report scores
on these scales for descriptive purposes, converting one trial
using the Clinical Outcomes in Routine Evaluation Outcome
Measure (CORE-OM)26 to BDI scores using published
algorithms27 to maximise comparability. For the main analysis
we standardised scores within each study, using study-specific
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Box 1: Stepped care
Stepped care is a system of delivering health technologies, where the most effective yet least resource intensive treatment is delivered
to patients first
In depression care, conventional psychological therapies such as cognitive behavioural therapy (so called high intensity therapies
involving 12–16 sessions from an experienced practitioner) are effective, but demand outstrips supply, leading to long waiting lists
Less resource intensive versions, delivered via books and information technology with limited support and guidance from a professional,
have been developed (so called low intensity interventions)
Stepped care is intended to enhance efficiency by providing low intensity interventions to a proportion of depressed patients in the first
instance, before providing higher intensity interventions to those who do not improve with the low intensity interventions. Stepped care
is best seen as the product of two simple principles:
1. The principle of “least burden”—Effective low intensity interventions are offered to patients first, and high intensity interventions offered
only to patients who are at risk to self or others, have a history of treatment failure, or do not improve from initial treatment
2. The principle of “scheduled review”—This is required so that patients can “step up” to more intensive interventions, or change to
another intervention within the same step, if they fail to meet consensus criteria for improvement or recovery. Scheduled reviews use
objective outcome measures to assist decision making
means of the follow-up scores and the standard deviations of
the baseline scores. Patients participating in low intensity trials
may be selected to be appropriate for these interventions, and
there may be limits on the severity of patients included in such
trials, restricting our ability to test the moderating effects of
severity at the higher range.We assessed the severity of patients
included in these trials, both in terms of inclusion and exclusion
criteria, and the BDI and CES-D scores of patients actually
recruited.
Missing data
We assumed data were missing at random, and we imputed
missing age and depression scores at follow-up using a
multivariate imputation algorithm (“mi impute mvn,” in Stata
version 11) using Markov Chain Monte Carlo. Multiple
imputation is currently the most sophisticated approach to deal
with missing data and is recommended over single
imputation.28 29 Themethod generates several datasets, analysing
each one separately using the selected model, and combines the
results. We generated 1000 new datasets with the observed and
imputed scores for age and follow-up depression scores from
study, treatment group, baseline depression score, and sex.
Predicted scores were limited to ranges appropriate for each
scale. Convergence of the imputation algorithms was verified
with time series and autocorrelation plots of the worst linear
function.30 31We tested whether baseline variables (study, group
allocation, age, sex, and baseline depression) predicted missing
data to test the assumptions underlying imputation. We also
conducted a sensitivity analysis using only cases with available
data.
Analysis
As individual patient data meta-analyses are vulnerable to
publication bias from a number of sources,32 two authors
independently extracted data on populations, interventions,
methodological quality (based on assessment of allocation
concealment, intention to treat analysis, and attrition) and
outcome effect sizes for all studies identified by the searches,
so as to compare the studies where data were available to us
with those where data were unavailable.We present descriptive
statistics on study characteristics (including quality, in terms of
concealment of allocation, reporting of intention to treat analysis,
and attrition rates of <20%). We also assessed the potential for
publication bias using funnel plots, in line with published
recommendations.32 We also extracted data on moderator
analyses in published studies to allow further comparisons.
There are three methods of analysing moderator effects in
meta-analysis: aggregate data analysis throughmeta-regression;
using individual patient data to estimate the treatment-moderator
interaction within each study, followed by a standard inverse
variance meta-analysis (“two step analysis”); and analysis of
individual patient data using a mixed model and accounting for
clustering of patients within studies (“one step analysis”).14 18
In certain situations these last two analyses give identical results,
although they differ under conditions such as “covariate
heterogeneity” (that is, the variation in the covariate within each
study).14
In this study we used the one step analysis, which is the most
logistically demanding but which allows for sophisticated
modelling of covariates (in this case, age, sex, and baseline
severity), is least affected by bias, and is most efficient in terms
of power.33 34 Appropriate mixed effects models (with fixed
trial-specific intercepts for the interaction, a random treatment
effect, and fixed trial-specific effects for baseline) were used to
synthesise the patient level data and estimate the variances
between and within studies, fitting the interaction as a
continuous variable.35 We also repeated these analyses with
different meta-analytic models (random trial intercept; random
treatment effect; fixed trial-specific effects for baseline). We
used Stata v12.1 and a restricted maximum likelihood algorithm
with the “xtmixed” command.36 37 Heterogeneity was assessed
using the I2 statistic.38 For cluster randomised studies, we
adjusted appropriately.39 Where studies involved multiple
treatment comparisons with a single control, we treated each
comparison separately, andwe avoided double counting controls
by assigning half the controls at random to each comparison.
We conducted two pre-specified secondary analyses to assess
the robustness of the results. We explored whether the overall
moderating effects of baseline severity were substantively
different at the highest levels of baseline severity (that is, to test
whether there was a non-linear effect at the highest levels of
depression severity). We split the data into five equally sized
groups on the basis of the initial severity of patients (rather than
two as specified in the protocol) and assessed the moderating
effect of baseline severity in each group.
We also assessed whether the main result was influenced by
study quality. Although the comprehensive Cochrane risk of
bias tool40 is widely used, we needed a measure of quality that
could be used in the quantitative analysis. We chose a
dichotomous measure based on allocation concealment, as this
is the aspect of quality most consistently associated with
treatment effect,41 42 is particularly relevant when outcomes are
subjective,43 and because other measures included in the risk of
bias tool, such as blinding, are generally less useful in trials of
psychological therapy because the conditions for blinding are
so rarely met and most outcomes are self reported. Allocation
concealment was judged as adequate or inadequate according
to the relevant section from the Cochrane risk of bias tool.
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We also coded the types of low intensity interventions: internet
versus written forms, and “guided” (low intensity interventions
with limited support by a health professional) versus “unguided”
forms (used by the patient alone). An additional post hoc
secondary analysis explored whether the main result was
influenced by the outcome measure used (BDI or CES-D).
Results
Figure 1⇓ shows the process of study selection for our review.
We excluded six potentially eligible studies because numbers
of participants were below 50, five because they were published
before 2000, and four on both criteria. We identified 29
comparisons as being potentially eligible. There was moderate
evidence of asymmetry in the funnel plot for these studies
(Egger’s regression test intercept −2.4 (SE 0.8), P=0.007, fig
2⇓). We gained access to data from 16 (55%) of these
comparisons, with data unavailable either because of no response
from authors (n=8), clashes with their own planned analyses
(n=4), or ethical issues with sharing data (n=1). A small number
of individual cases were dropped because of missing baseline
age or depression scores, leaving 2470 unique cases, with 77%
reporting data at first follow-up. Group allocation had the
strongest association with missing follow-up data, with patients
in the usual care group less likely to have missing outcome data.
Such patterns of missing data might be expected to result in an
inflation of the overall effect (if missing data was associated
with poor outcomes), but the effect on the interaction is difficult
to predict.
Available and unavailable data
Data on study characteristics and design are detailed in the
“Additional resources” file on bmj.com.We compared available
and unavailable studies on population, intervention, quality,
and outcome data (see table⇓). Studies were similar in
recruitment procedures, although available studies were less
likely to involve patients with a diagnosis of depression or health
technologies delivered via information technology, but were
more likely to involve support from a health professional.
Available studies met more quality criteria, had a slightly larger
sample size, and reported lower estimates of effect.
Baseline characteristics of patients included
in the review
As noted earlier, patients participating in low intensity trials are
selected to be appropriate for these interventions, so we assessed
the severity of depression of patients included in these trials.
Six studies (38%) had a maximum ceiling for inclusion.
Assessment of mean depression scores at baseline showed that
many patients had appreciable symptoms (see fig 3⇓). For the
BDI score (range 0–63), a score of 10–16 indicates mild
depression, 17–29 indicates moderate depression, and ≥30
indicates severe depression: the studies’ mean scores were
19–21,44 21,45 22,46 23–24,47 23–28,48 26,49 27,50 27–28,51 and
29.52 For the CES-D score (range 0–60), a score of ≥16 indicates
a probable depressive illness, and the studies’ mean scores
ranged from 13 in a trial focussed on subthreshold symptoms53
to 21–22,54 30,55 and 32.56
In terms of other characteristics of the patients, comparisons
are limited by the data presented and reflect study inclusion
criteria, but generally two thirds to three quarters of patients
were women, with mean ages 35–45 years, and with rates of
university education ranging from 20% to 65%. In terms of
treatment history, rates of current antidepressant use (where
reported) ranged from 19% to 69%, and between 38% and 67%
reported a previous treatment for depression.
Is the effect of low intensity interventions on
depressionmoderated by baseline depression
severity?
The overall standardised estimate of the main effect of low
intensity interventions was −0.42 (95% confidence interval
−0.55 to −0.29, I2=2.9% (0.5% to 15%)). This would be
equivalent to an additional drop of around four or five points
on both BDI and CES-D scores, over and above the change in
the controls. There was no evidence that this main effect varied
by age, sex, intervention type, or study quality. When a term
was added to assess the interaction, we found a significant
negative interaction between baseline severity and treatment
effect (interaction coefficient −0.1 (−0.19 to −0.002)). This
suggests that patients who are more severely depressed at
baseline demonstrate larger treatment effects than those who
are less severely depressed. However, the magnitude of the
interaction is small. As scores had been standardised, the effect
represented an additional standardised benefit of 0.1 for an
increase in initial severity of one standard deviation, which
would be equivalent to an additional drop of around one point
on both BDI and CES-D for a one standard deviation increase
in initial severity, an effect which may not be clinically
significant. The interpretation of the main result is outlined in
clinical terms in box 2.
Figure 4⇓ shows the estimates of the interactions at the level of
the individual studies. The estimate was similar when conducted
on available data without imputation (−0.12 (95% confidence
interval −0.22 to −0.02)) and was not sensitive to variation in
the meta-analytic model specified or the different measures
included in the trials (BDI or CES-D score).
Is there a moderating effect of baseline
depression severity at higher levels of
depression?
The main analysis reported in the previous section showed a
small but significant increase in effect of low intensity
interventions in patients with more severe depression at
presentation. When data were analysed in terms of five severity
subgroups, we observed a stepwise increase in the effect of low
intensity interventions, from least to most severely ill patients,
but there was no statistically significant difference in the effect
across the groups. Thus there was no indication that patients at
the highest levels of severity showed different effects to the
overall trend.
Are the results sensitive to allocation
concealment?
Themoderating effect of initial depression was larger in patients
in studies with adequate concealment of allocation, but the
difference was not statistically significant (interaction coefficient
−0.07 (95% confidence interval −0.34 to 0.21)).
Are the results sensitive to types of low
intensity interventions?
Themoderating effect of initial depression was larger in patients
in the studies that used internet based low intensity interventions,
compared with the studies that used written interventions, but
the difference was not statistically significant (interaction
coefficient −0.09 (−0.31 to 0.12)). The moderating effect of
initial depression was also greater in patients who used unguided
low intensity interventions, compared with those who used
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Box 2: Clinical scenario
Patients attending primary care and considered eligible for psychological therapy for depression may present with a Beck Depression
Inventory (BDI) score of around 25 (out of a maximum of 63), indicating moderate severity of depression. After three to six months in usual
primary care, without any intervention, such patients might be expected to reduce their score on average by four points to around 21, still
indicative of moderate depression.
If such patients were referred to a low intensity intervention, they might be expected to display an additional reduction of four points on
average, over and above this natural change over time, to a score of around 17, indicative of milder depression.
The evidence presented in this paper would suggest that patients who present with more severe problems (such as a presenting score of
35) would show an additional drop of around one point (a total reduction of around five points) compared with those with an initial score of
25.
The results are displayed visually below. The horizontal axis shows initial severity of depression, and the vertical axis shows severity at
follow-up. As can be seen from fig 5⇓, patients in the low intensity intervention group consistently demonstrate lower severity of depression
at follow-up than usual care patients. These lower scores are evident across the entire range of initial depression severity (that is, the lines
never cross). The additional benefit shown by patients treated with low intensity interventions increases as initial severity increases (that is,
the vertical distance between the lines increases as initial depression severity increases). However, the magnitude of this divergence is
relatively small and is unlikely to be clinically significant.
The data illustrate that:
(a) low intensity interventions provide clinically significant benefits over usual care
(b) patients with more severe problems show greater levels of benefit from low intensity interventions, although the magnitude of that
additional benefit is modest and may not be clinically significant.
Although patients with more severe depression show greater benefits over usual care, their initial high scores mean that they are more likely
to continue to show clinically important levels of distress after low intensity interventions and may require additional care.
guided interventions, but again the difference was not significant
(interaction coefficient −0.07 (−0.30 to 0.15)).
Discussion
Principal findings
Data from 16 comparisons of low intensity interventions in
depression showed that patients with more severe depression
at baseline derive at least as much clinical benefit from the
interventions as less severely ill patients. We did not find
evidence that the main result was dependent on characteristics
of the studies, or the interventions, or major analytical
assumptions.
Strengths and weaknesses of the study
Although generally considered as a gold standard, meta-analyses
using individual patient data are potentially vulnerable to
publication bias (selective publication of significant results in
primary studies), reviewer selection bias (selective identification
of relevant datasets of individual patient data) and availability
bias (selective access to individual patient datasets once
identified). The funnel plot suggested some potential for
publication bias in the general literature around low intensity
interventions. Reviewer selection bias was reduced by the search
methods (using published systematic reviews and a search for
recent studies). In terms of availability bias, a recent review
found that the proportion of available patients in individual
patient data analyses ranged from 66% to 98%.32 We were able
to access just over half of the eligible studies and patients. As
well as a relatively high level of unavailable data, the trials with
available data differed in important ways from the entire
literature. The results may not generalise as clearly to patient
populations with a formal diagnosis of depression, to
computerised low intensity interventions, and to unguided
interventions. The diagnosis issue is probably the key limitation,
as it relates most clearly to the core research question. It should
be noted that the studies available to the review met more of
our quality criteria (allocation concealment, intention to treat
analyses, and low attrition) than studies where data were
unavailable (see table⇓), with over 80% reporting adequate
concealment of allocation.
As noted previously, it is possible that patients with severe
depression (and therefore more likely to receive a diagnosis)
would not enter these trials, so the analysis is unable to assess
their outcomes. However, it should be noted that the 10 trials
in the dataset that used the BDI score included 430 patients
(nearly a third of the total) with scores >30 (indicating severe
depression), which shows that these samples do not consist of
minor cases only. Our secondary analyses did not suggest that
the general direction of effects was different in the most severely
depressed patients. Figure 3⇓ would suggest that the results are
valid with scores of up to 40 on the two outcome measures. The
analysis assumes equivalence in the clinical meaning of change
at different levels of initial severity, such that the impact of a
reduction in scores for a patient who initially scores 30 is the
same as that for a patient scoring 16. This assumption is
conventional in trial analyses.
Although our results were robust to a range of sensitivity
analyses, it should be noted that the tests of three way
interactions (such as tests of whether the interaction of initial
severity and outcome differed in studies of different quality)
lacked precision.
Strengths andweaknesses in relation to other
studies
There are no comparable analyses in the literature of low
intensity interventions for depression. Thirteen comparisons in
the total dataset included some form of secondary analysis of
moderators (see table of study characteristics in “Additional
resources” on bmj.com), although the variables tested and the
analytical techniques used varied widely, and not all explored
severity. Of those examining initial severity of depression, four
comparisons suggested similar results in less and more severely
ill patients,54 57 58 one reported a greater benefit in less severely
ill patients,52 and the rest reported that more severely ill patients
showed greater benefits.51 55 59 The broad pattern thus confirms
the present findings, although issues with the analyses and power
of previous studies means that the current analysis has a rigour
and precision that a narrative analysis of patterns across
individual studies cannot match.
One recent meta-analysis assessed the impact of pre-treatment
severity on outcomes in conventional, “high intensity”
psychological therapies for outpatient depression.13
Meta-regression results showed that mean pre-treatment
depression scores did not generally predict intervention effects
across all studies. A subset of studies reported within-study
analyses, and the data from these suggested that, where effects
were demonstrated, they concurred with the present analysis in
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showing that higher initial severity was associated with greater
treatment effects.
Meaning of the study: possible explanations
and implications for clinicians and
policymakers
The lack of clinically meaningful differences in treatment effects
related to baseline severity would suggest that it is legitimate
to include low intensity interventions in the first step of a
stepped care system and to encourage most patients to use them
as the initial treatment option, even when initial severity of
depression is high. Clearly some patients will not find such
interventions useful, and it would seem sensible to continue to
refer severe cases to more intense psychological intervention
or pharmacological management until further evidence is
generated confirming our findings. The current data suggest
that the threshold could be relatively high if patients are willing
to engage in low intensity interventions.
There are caveats to that recommendation. It is important to
note that we have modelled the impact of initial severity only
on the comparative effectiveness of low intensity interventions.
Even thoughmore severely ill patients show comparable benefit
to less severely ill patients, their high initial scores mean that
many remain symptomatic and do not meet conventional
thresholds for “recovery.” The second critical aspect of stepped
care systems (see box 1) is that all patients are monitored
consistently after any treatment to assess progress and ensure
that those with residual symptoms receive additional care to
enhance the likelihood of long term recovery.60 It is possible
that immediate provision of high intensity interventions to
patients with more severe depression would be more cost
effective than initial use of low intensity interventions followed
by high intensity therapy. Secondly, it is possible that initial
experience with low intensity interventions (especially if
unsuccessful) could act as a barrier to further treatment. Data
to explore either of these hypotheses are not available at present,
and this remains an important research question for the future.
It remains to be seen what other patient factors might need to
be taken into account in clinical decisionmaking. The traditional
model of evidence based practice would suggest that patients’
needs and preferences are important, but the evidence
demonstrating a relationship between preferences and outcome
is inconsistent.61 62 The effects of preferences could in principle
be tested in a similar way to the current analysis if baseline data
were reported consistently.62
Unanswered questions and future research
Our results show that some of the concerns about examination
of moderators in clinical trials (especially those around sample
size) can be overcome through collaborative meta-analysis of
individual patient data. It is important that the ethical and
logistical barriers to such data sharing are removed, and
appropriate incentives put in place to encourage such analyses
to answer clinically relevant questions.
Our analysis highlights the potential for more effective
collaboration around data sharing to enable appropriately
powered secondary subgroup analyses, with the potential to
allowmore effective targeting of treatments to patients andmore
personalised care. However, it is important to note that there
may be far more effective predictors of outcomes than baseline
severity, including preferences62 and other psychological
variables relating to attitudes or aptitudes. Fully exploring these
issues will require a consistent approach to defining core
moderating variable data to be collected at baseline, similar to
calls around core outcome measures in trials,63 to allow
development of an evidence base to provide better guidance for
patients, health professionals, and policy makers about “what
works for whom” in depression.
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Table
Table 1| Comparison of available and unavailable studies. Values are numbers (percentages) unless stated otherwise
Available (n=16)Unavailable (n=13)Factor
13 (81)10 (77)Recruitment via screening (versus referral)
2 (13)6 (46)Depression diagnosis confirmed
10 (63)12 (92)Computerised delivery (versus bibliotherapy)
12 (75)6 (46)Guided minimal intervention
2.31.9Mean quality (0–3)*
156145Mean baseline number
−0.39 (−0.26 to −0.52)−0.47 (−0.27 to −0.68)Pooled effect size (95% CI)
*Number of quality criteria on which studies were judged as adequate (criteria were adequate concealment of allocation, reporting of intention to treat analysis,
and <20% attrition).
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Figures
Fig 1 Inclusion of studies in the review
Fig 2 Funnel plot of studies included in analysis with pseudo 95% confidence intervals. Egger’s regression intercept −2.39
(SE 0.8), P=0.007
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Fig 3 Baseline severity data of studies included in the review. Box and whisker plots show median, interquartile range,
minimum and maximum scores, and outliers
Fig 4 Forest plot of interactions between baseline severity of depression and effect of low intensity interventions
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Fig 5 How baseline severity of depression moderates the effect of low intensity interventions on depression
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